ERBB2 and breast cancer: A systematic review of fifteen studies analyzing a total of 8563 patients highlighted that a high NLR is associated with a poor OS and DFS in patients with BC especially in triple negative disease and HER-2 positive (HER2+) BC population rather than hormone receptor-positive (HR+) BC patients (35).